Details checkedClinical trial listing onlyHistorical/discontinuedCheckedregistry

Audiovestibular biomarker DNA biobanking study

Also known as: DNA bio-banking, Superficial siderosis DNA biobanking

Institution-led study

Primary source

Sponsor / Institution

Institution-led study

Program Type

Diagnostic

Modality

Genetic/Biomarker Study

Stage

Not applicable

Status

Completed

Target Gene

—

Route / Mode

Saliva sample collection

Confidence

88%

Status Confidence

Status needs checking

Evidence Strength

Needs more support

Last Reviewed

2026-06-10

Geography

United Kingdom

Population

adult, age-related, biomarker, rare-disease

Trial IDs

Mechanism

Saliva DNA biobanking plus hearing, vestibular, olfactory, imaging, and quality-of-life assessments in an observational biomarker study of infratentorial superficial siderosis and hearing loss.

Indications

Hearing Loss Age-Related Hearing Loss Vestibular Disorders

Notes

Registry-verified observational biomarker/biobanking study. This was previously misclassified as gene therapy; it does not represent a therapeutic genetic intervention.

Evidence & Sources

1 structured sources

clinicaltrials

Supports: canonicalName, company, allCompanies, isIndustrySponsored, programType, modality, mechanism, indications...

IDs: NCT04200664

Open

Key Events

2020-02-07

Audiovestibular biomarker study began

2021-10-19

Study completed

Clinical Trials (1)